Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OKUR compared with KPTI: revenue, margins and what each company keeps, and the suppliers and customers both name
OKUR
OnKure Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
KPTI
Karyopharm Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
OKUR
OnKure Therapeutics, Inc.
vs
KPTI
Karyopharm Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
OKUR: latest quarter not drawable. KPTI: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OKUR
2
—
PharmaBlock Sciences (Nanjing)
unlisted
supplier
—
STA Pharmaceutical Hong Kong
unlisted
supplier
Shared
0
No shared counterparties.
Only KPTI
6
BMY
Bristol-Myers Squibb
supplier
—
FORUS Therapeutics
unlisted
customer
—
Menarini
unlisted
customer
—
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Antengene Therapeutics
unlisted
customer
2 more · KPTI chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OKUR, solid
KPTI, dashed
OKUR
OnKure Therapeutics, Inc.
Change
2.63
· pre 2.63
· delayed
Mkt cap
$106.1M
Revenue
—
Revenue
—
KPTI
Karyopharm Therapeutics Inc.
Change
0.63
· pre 0.65
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$15.0M
Revenue
$33M
Q2 FY26
Revenue
$146M
FY25
vs
Compare
Pre-market
Oct 30 '26
delayed
OKUR
OnKure Therapeutics, Inc.
vs
KPTI
Karyopharm Therapeutics Inc.
2.63
pre 2.63
delayed
Price
0.63
pre 0.65
delayed
$106.1M
Mkt cap
$15.0M
—
Revenue
$33M
Q2 FY26
—
Revenue
$146M
FY25
Change
Change
OKUR
2.63
vs
KPTI
0.63
Pre-market
Oct 30 '26
delayed